Member Info for Jurado

The CEO made a similar statement not long before that placement - read the posts form that time, that's why it's understandable to be a mite skeptical now. I hope you are right - experience suggests caution.

Indeed Sieveco - I wonder how many of those who ridicule the idea of a placing were shareholders on 22 March this year?

Out of interest, what precisely is it that has seemingly persuaded a few thousand Mexicans to pay a dollar week for LivesScores - I assume it is something more than, erm, "live scores", and I assume it's something that doesn't cost MOS much to supply, in other words I don't think we're giving them The Athletic exactly. Anyone know the detail?

"Oxford Nanopore is raising money, not making money. Not sure where you enthusiasm comes from". Are you suggesting these two things are mutually exclusive Monty? Anyhow I think it is fair enough to be excited about the impact of the Oxford Nanopore IPO on our share price.

I sold a tranche at 2606 - taking five-bag profit but also with a view to trading, thinking it might have topped out. Looks like I was a pound out - may have to wait a bit to get back up to my previous holding. Whatever , tremendous performance by all concerned with the company.

Yep - 28 April. Do I think they will be good? Depends on what we think is good. We've all been waiting for the company to swing into the black, something which has obviously hit bumps in the road. I can only think that the biggest influence on balance sheet is the state of the pandemic in the USA and the level of operations being done that use our products. On that basis the last six months are unlikely to show huge improvement, but as long as we're still ok with funding to get through to profitability I'll see that as good enough. I think we (should) all still be in hold mode right now and maybe this time next we see serious change...same old story I know.

"They know! Nobody sells this close to good results!"

But they do of course. I seem to remember last July IPO selling their holding in Ceres a matter of hours before the SP went through the roof. It was hard to believe a major shareholder who had been in since the beginning wouldn't have known something was about to drop - but then when we pushed for an explanation at the AGM we got a simple "Sorry - we can't always get it right" response. My fairly obvious point then is, if someone is selling now - as it seems they are - they may not have it right.

Obvs the Nanopore IPO is the big news here for the next few months, but looking ahead for the next big beast in the portfolio does anyone have the knowledge to comment on the potential of PsiOxus? Today they confirmed ongoing collaboration with Bristol Meyers Squibb , which has to be promising but I don't have the insight to gauge whether this is anything more than just another longshot in the cancer stakes. We own nearly a quarter of the company.

Amazing to realise that while I've tenbagged here already, Phil's interview stresses we are still three years away from the big money rolling in when the licencing fees per kilowatt hour arrive from Bosch, Doosan etc. Suggests maybe limited scope for short-term trading, which is nice, though there are bound to be ups and downs over any three year period. I'll be reflecting hard on what my price would be for topping up on dips.

Ok, looking around for some good news for us, I note that US hospital admissions for covid are down 71 per cent from 9 January to 23 March (www.cdc.gov). Still a long way to go I am sure but the UK experience suggests that the vaccine impact on reducing hospitalisations from serious cases is quicker and greater than the impact on the number of infections. One can only hope that the back log of operations can start to be addressed and our lovely new facility can quickly move to full capacity.

I remember asking as a relatively newbie many years ago whether people thought this would ever pay a dividend and, understandably , no-one proffered an opinion. I'm rather pleased to have stayed in long enough to find out that it would. My first divi should get me a small round of drinks once the pubs reopen but every little helps.

It's not done any harm for Summit (SMMT) which moved to Nasdaq a couple of years back, and is 500 per cent up since beginning of 2020. Mere anecdote admittedly but I think of these two companies as similar because I bought them at the same time, as two biotech companies seemingly at the same early stage of development. Both have required a lot of patience and have had the odd nightmare moment but both are still in the game. Hope Rene can do do it here.

So if you are 18 per cent down at .235, you were in profit at .305 last week - by several thousand if you own 12 million. Sure we can't always pick the right time to sell, but more to the point, there's not much substance to moaning when the swing to profit is so small. Try being a TRP shareholder from a few years back - I need the sp to grow 6,000 times over on that one,

Obviously not an active board right now but following today's announcement of the disposal of Curious Drinks there may well be a few hundred new shareholders who are getting Chapel Down shares in exchange/compensation for their stake in Curious. I've never heard of the Aquis exchange - anything we should know?

Why would we be investing in AIM if we did not think we should 'pre-judge what a company may do in the future'? If we 'wait and see' we are surely unlikely to make money, no? As has been noted, different writers in the Telegraph can write very different takes on the company's prospects - which is fair enough - and it is our job , should we choose, to review the portents and make our own decision. I did that with Arm and did very nicely. I've also done very well here so far and am holding for more. I've plenty of losers elsewhere of course.

I think it's a 'don't want to be out of this over the weekend' moment.

The meeting will have started. Assuming no deferral is made I assume a vote is taken in public and we'll know the answer today. Or is that not how it works?

As several of us said last week to a new investor - 'this rapid rise has probably priced in success- don't panic if the price falls even after a good sales update'. This is barely an update, and SP performance in recent months suggests investors were hoping for a little more than 'slightly ahead of expectations'. Nothing to worry about here though - the investment case remains very strong.

Isap, first thing first, be very cautious about advice or comment on these boards. You have to do your own research and temper your views of the comments you see here with the knowledge that some people will have their own agenda to encourage others to buy or to sell. Anyway, well done for making a good purchase, although remember a profit is only really a profit once you crystalise it by selling and pocketing the money. I got in here quite recently at 1.9p so am very happy. Personally I'll be hanging for a bit longer yet because looking at the sales figures for the company and assessing the stage they are at, I think they will increasingly successful and the share price will continue to rise. We'll get a sales update soon but note that even if they are good, the market may already have accounted for that in the rise over the last month. Don't panic if the share price dips even after a good set of figures - the company does seem to have good prospects of several years of steep growth (particularly I would say as Biden's green agenda kicks in) and the SP will follow.

If the comparison is sxx - I'd be happy with breakeven (about 0.8), if it's what I sort of hoped for when I invested, then 2p plus would leave me not unhappy. But then we could be worth a lot more than that with following wind, so...